• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤坏死因子受体 2 介导的 JNK 信号通路需要内化和 AIP1 相关联。

Both internalization and AIP1 association are required for tumor necrosis factor receptor 2-mediated JNK signaling.

机构信息

Interdepartmental Program in Vascular Biology and Therapeutics, Yale University School of Medicine, 10 Amistad St., 401B, New Haven, CT 06520, USA.

出版信息

Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2271-9. doi: 10.1161/ATVBAHA.112.253666. Epub 2012 Jun 28.

DOI:10.1161/ATVBAHA.112.253666
PMID:22743059
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3421067/
Abstract

OBJECTIVE

The proinflammtory cytokine tumor necrosis factor (TNF), primarily via TNF receptor 1 (TNFR1), induces nuclear factor-κB (NF-κB)-dependent cell survival, and c-Jun N-terminal kinase (JNK) and caspase-dependent cell death, regulating vascular endothelial cell (EC) activation and apoptosis. However, signaling by the second receptor, TNFR2, is poorly understood. The goal of this study was to dissect how TNFR2 mediates NF-κB and JNK signaling in vascular EC, and its relevance to in vivo EC function.

METHODS AND RESULTS

We show that TNFR2 contributes to TNF-induced NF-κB and JNK signaling in EC as TNFR2 deletion or knockdown reduces the TNF responses. To dissect the critical domains of TNFR2 that mediate the TNF responses, we examine the activity of TNFR2 mutant with a specific deletion of the TNFR2 intracellular region, which contains conserved domain I, domain II, domain III, and 2 TNFR-associated factor-2-binding sites. Deletion analyses indicate that different sequences on TNFR2 have distinct roles in NF-κB and JNK activation. Specifically, deletion of the TNFR-associated factor-2-binding sites (TNFR2-59) diminishes the TNFR2-mediated NF-κB, but not JNK activation; whereas, deletion of domain II or domain III blunts TNFR2-mediated JNK but not NF-κB activation. Interestingly, we find that the TNFR-associated factor-2-binding sites ensure TNFR2 on the plasma membrane, but the di-leucine LL motif within the domain II and aa338-355 within the domain III are required for TNFR2 internalization as well as TNFR2-dependent JNK signaling. Moreover, domain III of TNFR2 is responsible for association with ASK1-interacting protein-1, a signaling adaptor critical for TNF-induced JNK signaling. While TNFR2 containing the TNFR-associated factor-2-binding sites prevents EC cell death, a specific activation of JNK without NF-κB activation by TNFR2-59 strongly induces caspase activation and EC apoptosis.

CONCLUSIONS

Our data reveal that both internalization and ASK1-interacting protein-1 association are required for TNFR2-dependent JNK and apoptotic signaling. Controlling TNFR2-mediated JNK and apoptotic signaling in EC may provide a novel strategy for the treatment of vascular diseases.

摘要

目的

促炎细胞因子肿瘤坏死因子(TNF)主要通过 TNF 受体 1(TNFR1)诱导核因子-κB(NF-κB)依赖性细胞存活,以及 c-Jun N 端激酶(JNK)和半胱天冬酶依赖性细胞死亡,调节血管内皮细胞(EC)的激活和凋亡。然而,第二个受体 TNFR2 的信号转导知之甚少。本研究的目的是剖析 TNFR2 如何介导血管 EC 中的 NF-κB 和 JNK 信号转导,以及其与体内 EC 功能的相关性。

方法和结果

我们表明,TNFR2 有助于 TNF 诱导的 EC 中 NF-κB 和 JNK 信号转导,因为 TNFR2 缺失或敲低会降低 TNF 的反应。为了剖析介导 TNF 反应的 TNFR2 的关键结构域,我们检查了具有 TNFR2 细胞内区特定缺失的 TNFR2 突变体的活性,该缺失区包含保守的 I 结构域、II 结构域、III 结构域和 2 个 TNFR 相关因子-2 结合位点。缺失分析表明,TNFR2 上的不同序列在 NF-κB 和 JNK 激活中具有不同的作用。具体来说,TNFR 相关因子-2 结合位点(TNFR2-59)的缺失会减弱 TNFR2 介导的 NF-κB,但不会减弱 JNK 激活;而 II 结构域或 III 结构域的缺失会减弱 TNFR2 介导的 JNK,但不会减弱 NF-κB 激活。有趣的是,我们发现,TNFR 相关因子-2 结合位点确保了 TNFR2 位于质膜上,但 II 结构域内的双亮氨酸 LL 基序和 III 结构域内的 aa338-355 是 TNFR2 内化以及 TNFR2 依赖性 JNK 信号所必需的。此外,TNFR2 的 III 结构域负责与 ASK1 相互作用蛋白-1 结合,后者是 TNF 诱导的 JNK 信号所必需的信号衔接蛋白。虽然含有 TNFR 相关因子-2 结合位点的 TNFR2 可防止 EC 细胞死亡,但 TNFR2-59 特异性激活 JNK 而不激活 NF-κB 会强烈诱导半胱天冬酶激活和 EC 凋亡。

结论

我们的数据表明,TNFR2 依赖的 JNK 和凋亡信号转导需要内化和 ASK1 相互作用蛋白-1 结合。控制 EC 中 TNFR2 介导的 JNK 和凋亡信号转导可能为血管疾病的治疗提供新策略。

相似文献

1
Both internalization and AIP1 association are required for tumor necrosis factor receptor 2-mediated JNK signaling.肿瘤坏死因子受体 2 介导的 JNK 信号通路需要内化和 AIP1 相关联。
Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2271-9. doi: 10.1161/ATVBAHA.112.253666. Epub 2012 Jun 28.
2
AIP1/DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2-induced ASK1-JNK activation.AIP1/DAB2IP是Ras - GAP家族的一个新成员,可传导TRAF2诱导的ASK1 - JNK激活。
J Biol Chem. 2004 Oct 22;279(43):44955-65. doi: 10.1074/jbc.M407617200. Epub 2004 Aug 13.
3
TNFR2 increases the sensitivity of ligand-induced activation of the p38 MAPK and NF-κB pathways and signals TRAF2 protein degradation in macrophages.肿瘤坏死因子受体 2(TNFR2)增加配体诱导的丝裂原活化蛋白激酶(p38 MAPK)和核因子-κB(NF-κB)通路的激活敏感性,并在巨噬细胞中信号转导 TRAF2 蛋白降解。
Cell Signal. 2014 Apr;26(4):683-90. doi: 10.1016/j.cellsig.2013.12.009. Epub 2013 Dec 27.
4
Tumor necrosis factor receptor 2 (TNFR2) signaling is negatively regulated by a novel, carboxyl-terminal TNFR-associated factor 2 (TRAF2)-binding site.肿瘤坏死因子受体2(TNFR2)信号传导受到一个新的羧基末端肿瘤坏死因子受体相关因子2(TRAF2)结合位点的负调控。
J Biol Chem. 2005 Sep 9;280(36):31572-81. doi: 10.1074/jbc.M504849200. Epub 2005 Jul 14.
5
Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation.心力衰竭中不同的肿瘤坏死因子受体相关重塑反应:核因子-κB和炎症激活的作用
Circulation. 2009 Mar 17;119(10):1386-97. doi: 10.1161/CIRCULATIONAHA.108.802918. Epub 2009 Mar 2.
6
TNFR1 delivers pro-survival signals that are required for limiting TNFR2-dependent activation-induced cell death (AICD) in CD8+ T cells.TNFR1 传递生存信号,这些信号对于限制 CD8+T 细胞中 TNFR2 依赖性激活诱导的细胞死亡 (AICD) 是必需的。
Eur J Immunol. 2011 Feb;41(2):335-44. doi: 10.1002/eji.201040639. Epub 2010 Dec 29.
7
RIP1-mediated AIP1 phosphorylation at a 14-3-3-binding site is critical for tumor necrosis factor-induced ASK1-JNK/p38 activation.RIP1介导的AIP1在14-3-3结合位点的磷酸化对于肿瘤坏死因子诱导的ASK1-JNK/p38激活至关重要。
J Biol Chem. 2007 May 18;282(20):14788-96. doi: 10.1074/jbc.M701148200. Epub 2007 Mar 27.
8
Release of nonmuscle myosin II from the cytosolic domain of tumor necrosis factor receptor 2 is required for target gene expression.肿瘤坏死因子受体 2 的胞质结构域中非肌球蛋白 II 的释放对于靶基因表达是必需的。
Sci Signal. 2013 Jul 16;6(284):ra60. doi: 10.1126/scisignal.2003743.
9
TRAF2 multitasking in TNF receptor-induced signaling to NF-κB, MAP kinases and cell death.TRAF2在肿瘤坏死因子受体诱导的向核因子κB、丝裂原活化蛋白激酶的信号传导及细胞死亡过程中的多重任务作用
Biochem Pharmacol. 2016 Sep 15;116:1-10. doi: 10.1016/j.bcp.2016.03.009. Epub 2016 Mar 16.
10
Novel anti-apoptotic mechanism of A20 through targeting ASK1 to suppress TNF-induced JNK activation.通过靶向 ASK1 抑制 TNF 诱导的 JNK 激活,A20 具有新颖的抗凋亡机制。
Cell Death Differ. 2010 Dec;17(12):1830-41. doi: 10.1038/cdd.2010.47. Epub 2010 May 7.

引用本文的文献

1
Targeting TNFR2 for cancer immunotherapy: recent advances and future directions.针对肿瘤免疫疗法的 TNFR2 靶点:最新进展和未来方向。
J Transl Med. 2024 Sep 2;22(1):812. doi: 10.1186/s12967-024-05620-x.
2
Involvement of the tumour necrosis factor receptor system in glioblastoma cell death induced by palbociclib-heptamethine cyanine dye conjugate.帕博西尼-七甲川花菁染料缀合物诱导胶质母细胞瘤细胞死亡过程中肿瘤坏死因子受体系统的参与。
Cell Commun Signal. 2024 Jan 11;22(1):30. doi: 10.1186/s12964-023-01277-z.
3
TNF and TNF receptors as therapeutic targets for rheumatic diseases and beyond.

本文引用的文献

1
NF-kappaB signal triggering and termination by tumor necrosis factor receptor 2.肿瘤坏死因子受体 2 触发和终止 NF-κB 信号。
J Biol Chem. 2011 Jul 1;286(26):22814-24. doi: 10.1074/jbc.M111.225631. Epub 2011 May 10.
2
Tumor necrosis factor receptor cross-talk.肿瘤坏死因子受体相互作用。
FEBS J. 2011 Apr;278(6):888-98. doi: 10.1111/j.1742-4658.2011.08017.x. Epub 2011 Feb 8.
3
TNFR1-induced activation of the classical NF-κB pathway.肿瘤坏死因子受体 1 诱导的经典 NF-κB 通路的激活。
肿瘤坏死因子(TNF)及其受体作为治疗风湿性疾病及其他疾病的靶点。
Nat Rev Rheumatol. 2023 Sep;19(9):576-591. doi: 10.1038/s41584-023-01002-7. Epub 2023 Aug 4.
4
The dichotomous outcomes of TNFα signaling in CD4 T cells.TNFα 信号在 CD4 T 细胞中的双重结局。
Front Immunol. 2022 Nov 16;13:1042622. doi: 10.3389/fimmu.2022.1042622. eCollection 2022.
5
Targeting TNFR2: A Novel Breakthrough in the Treatment of Cancer.靶向肿瘤坏死因子受体2(TNFR2):癌症治疗中的一项新突破。
Front Oncol. 2022 Apr 14;12:862154. doi: 10.3389/fonc.2022.862154. eCollection 2022.
6
The Signaling Pathway of TNF Receptors: Linking Animal Models of Renal Disease to Human CKD.肿瘤坏死因子受体信号通路:将肾脏疾病的动物模型与人类慢性肾脏病联系起来。
Int J Mol Sci. 2022 Mar 18;23(6):3284. doi: 10.3390/ijms23063284.
7
Cytokine TNF-α and its receptors TNFRI and TNFRII play a key role in the in vitro proliferative response of BLV infected animals.细胞因子 TNF-α 及其受体 TNFRI 和 TNFRII 在 BLV 感染动物的体外增殖反应中发挥关键作用。
Vet Res Commun. 2021 Dec;45(4):431-439. doi: 10.1007/s11259-021-09825-z. Epub 2021 Aug 27.
8
Impact of Endocytosis Mechanisms for the Receptors Targeted by the Currently Approved Antibody-Drug Conjugates (ADCs)-A Necessity for Future ADC Research and Development.内吞作用机制对目前已获批抗体药物偶联物(ADC)所靶向受体的影响——未来ADC研发的必要性
Pharmaceuticals (Basel). 2021 Jul 15;14(7):674. doi: 10.3390/ph14070674.
9
Activation of c-Jun N-Terminal Kinase, a Potential Therapeutic Target in Autoimmune Arthritis.c-Jun N-末端激酶的激活,在自身免疫性关节炎中具有潜在的治疗靶点。
Cells. 2020 Nov 12;9(11):2466. doi: 10.3390/cells9112466.
10
MicroRNA-146b-5p overexpression attenuates premature ovarian failure in mice by inhibiting the Dab2ip/Ask1/p38-Mapk pathway and γH2A.X phosphorylation.miRNA-146b-5p 过表达通过抑制 Dab2ip/Ask1/p38-Mapk 通路和 γH2A.X 磷酸化来减轻小鼠卵巢早衰。
Cell Prolif. 2021 Jan;54(1):e12954. doi: 10.1111/cpr.12954. Epub 2020 Nov 9.
FEBS J. 2011 Apr;278(6):862-76. doi: 10.1111/j.1742-4658.2011.08015.x. Epub 2011 Feb 8.
4
Functional analyses of the bone marrow kinase in the X chromosome in vascular endothelial growth factor-induced lymphangiogenesis.在血管内皮生长因子诱导的淋巴管生成中,对 X 染色体上骨髓激酶的功能分析。
Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2553-61. doi: 10.1161/ATVBAHA.110.214999. Epub 2010 Sep 23.
5
Ligand-induced internalization of TNF receptor 2 mediated by a di-leucin motif is dispensable for activation of the NFκB pathway.配体诱导的二亮氨酸基序介导的 TNF 受体 2 内化对于 NFκB 途径的激活是不必要的。
Cell Signal. 2011 Jan;23(1):161-70. doi: 10.1016/j.cellsig.2010.08.016. Epub 2010 Aug 31.
6
Targeting of tumor necrosis factor receptor 1 to low density plasma membrane domains in human endothelial cells.靶向人内皮细胞低密度质膜域的肿瘤坏死因子受体 1。
J Biol Chem. 2010 Jul 30;285(31):23868-79. doi: 10.1074/jbc.M110.122853. Epub 2010 May 28.
7
Endothelial-specific transgenesis of TNFR2 promotes adaptive arteriogenesis and angiogenesis.内皮细胞特异性转染 TNFR2 促进适应性动脉生成和血管生成。
Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1307-14. doi: 10.1161/ATVBAHA.110.204222. Epub 2010 Apr 15.
8
Membrane tumor necrosis factor (TNF) induces p100 processing via TNF receptor-2 (TNFR2).膜型肿瘤坏死因子 (TNF) 通过 TNF 受体-2 (TNFR2) 诱导 p100 加工。
J Biol Chem. 2010 Mar 5;285(10):7394-404. doi: 10.1074/jbc.M109.037341. Epub 2009 Dec 28.
9
Mechanisms of endothelial dysfunction, injury, and death.内皮功能障碍、损伤及死亡的机制。
Annu Rev Pathol. 2009;4:71-95. doi: 10.1146/annurev.pathol.4.110807.092155.
10
Regulation of TNFR1 and CD95 signalling by receptor compartmentalization.通过受体区室化对肿瘤坏死因子受体1(TNFR1)和CD95信号传导的调控
Nat Rev Mol Cell Biol. 2008 Aug;9(8):655-62. doi: 10.1038/nrm2430. Epub 2008 Jun 11.